Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/f976caa2-35a9-4e7a-ac13-e3c446f9d832/
ACL
Australian Clinical Labs LimitedSnapshot 2026-07-12 · 0.7w · Fresh
Strategy Eligibility
7 of 23 passing
★
OS Composite
OS 0.860
↗
Trending Value
✗
◆
Quality × Value
QV 0.965
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
VC2 4
📐
EBITDA/EV
27.5%
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
10.4%
💰
High Yield
Div 5.7%
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
Val 95%
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
95.0%ile
P/E
12.8×
P/S
0.6×
P/B
2.4×
E/P
0.0920
FCF Yield
0.255
EBITDA/EV
0.275
SH Yield
0.104
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
6.00000000
/100 — 1=cheapest
VC2 (Trending Value)
4.00000000
/100
VC3 (Buyback)
4.00000000
/100
FCF yield of 25.5% is strong — the business generates significant free cash relative to price. VC2 score of 4.00000000/100 puts this in the cheapest decile of the universe — prime Trending Value territory.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
98.0%ile
ROE
0.189
ROA
0.056
Net Margin
0.044
Op Margin
0.085
GPA
1.058
Current
0.55
F-Score
5/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.067
Earn Growth
0.397
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
9.0%ile
6M Return
-16.6%
12M Return
-15.5%
12-1 Mom
-17.8%
Risk-Adj
-0.58
Vol 252d
30.5%
Vol 60d
61.5%
↑ Expanding
Max DD 12M
-34.0%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of -18% signals a downtrend — price is moving against you. Near-term vol (62%) is expanding vs long-term (31%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.86
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 145 peers
Sector Value %ile
100.0%
Sector Quality %ile
97.9%
P/E z-score
-0.49
P/B z-score
-0.40
Sector Avg OS
39.7%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Value + Quality Intersection
Top-tier on both cheapness (95th) and quality (98th) — the O'Shaughnessy sweet spot, historically the strongest long-term combination.
Falling Knife
Weak momentum (9th) despite looking cheap (95th value). Wait for momentum to stabilise.
Strong Capital Return
Shareholder yield 10.4% backed by 25.5% FCF yield. Returns are well-funded.
Volatility Expanding
60-day vol (62%) significantly exceeds 252-day (31%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
A
88.1% avg (7 factors)
Quality
D
42.4% avg (6 factors)
Momentum
F
13.2% avg (4 factors)
Risk
B
65.8% avg (1 factors)
Deep value territory, but quality is concerning. This is either a turnaround opportunity or a value trap — the F-Score and accruals ratio will be key differentiators. Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends6 snapshots
Factor Persistence6 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.860 | —6 | — | |
| Value %ile | 0.950 | —6 | — | |
| Quality %ile | 0.980 | —6 | — | |
| Momentum %ile | 0.090 | —6 | — | |
| F-Score | 5.000 | —0 | — | |
| Confidence | 0.470 | —0 | — | |
| Volatility | 0.305 | —0 | — |
Value Lens2021-07-13 → 2026-07-12
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
12.77
Earnings Yield (E/P)
0.0920
Price / Sales
0.56
Price / Book
2.42
FCF Yield
25.5%
EBITDA / EV
27.5%
Sales Yield (1/P·S)
1.0768
Shareholder Yield
Div + net buyback / mktcap
10.4%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
18.9%
Return on Assets
5.6%
Net Margin
4.4%
Operating Margin
8.5%
Gross Profit / Assets
Novy-Marx GPA
105.8%
Current Ratio
0.55
MomentumPrice trend strength over different horizons
6M Return
-16.6%
12M Return
-15.5%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-17.8%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-0.58
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
6.7%
Earnings Growth (YoY)
39.7%
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
5
Dividend Yield
5.7%
Buyback Yield
4.6%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
6
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
4
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
4
Trending Value Rank
1=best. Top VC2 decile by 6M momentum
54
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity